| Shavash Safvati M D Inc | |
|
12626 Riverside Dr Suite #303 North Hollywood CA 91607-3420 | |
| (818) 760-2434 | |
| (818) 760-8832 |
| Full Name | Shavash Safvati M D Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 12626 Riverside Dr, North Hollywood, California |
| Authorized Official Name and Position | Shavash Safvati (PRESIDENT) |
| Authorized Official Contact | 8187602434 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Shavash Safvati M D Inc 12626 Riverside Dr Suite #303 North Hollywood CA 91607-3420 Ph: (818) 760-2434 | Shavash Safvati M D Inc 12626 Riverside Dr Suite #303 North Hollywood CA 91607-3420 Ph: (818) 760-2434 |
| NPI Number | 1144536228 |
|---|---|
| Provider Enumeration Date | 08/26/2010 |
| Last Update Date | 06/26/2023 |
| Medicare PECOS PAC ID | 6204950702 |
|---|---|
| Medicare Enrollment ID | O20100907000524 |
News Archive
AbbVie, a global biopharmaceutical company, today announced that it will advance ABT-494, its internally developed investigational selective JAK1 inhibitor, to Phase 3 studies in rheumatoid arthritis. Following a thorough review of available data, AbbVie will not exercise its right to in-license the Galapagos JAK1 inhibitor, filgotinib.
Iron supplementation reduced fatigue by almost 50% in women who are low in iron but not anemic, according to the results of a clinical trial published July 9 in CMAJ (Canadian Medical Association Journal).
Cardiome Pharma Corp. (NASDAQ: CRME/TSX: COM) and its co-development partner Astellas Pharma US, Inc. ("Astellas") announced today that Astellas will undertake a single confirmatory additional Phase 3 clinical trial of KYNAPID(TM) (vernakalant hydrochloride) Injection for rapid conversion of atrial fibrillation to sinus rhythm. The trial, to be called ACT 5, is expected to begin enrolling patients by the end of 2009, with completion expected in the first half of 2011.
The American Academy of Physician Assistants and the American College of Physicians today released a policy monograph that supports the critical roles physician assistants and physicians play in improving access to high-quality primary care. The paper, "Internists and Physician Assistants: Team-based Primary Care," results from a months-long collaborative project.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144536228 | NPI | - | NPPES |
| 00A498420 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Shavash Safvati |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1083704076 PECOS PAC ID: 3870554736 Enrollment ID: I20100907000496 |
News Archive
AbbVie, a global biopharmaceutical company, today announced that it will advance ABT-494, its internally developed investigational selective JAK1 inhibitor, to Phase 3 studies in rheumatoid arthritis. Following a thorough review of available data, AbbVie will not exercise its right to in-license the Galapagos JAK1 inhibitor, filgotinib.
Iron supplementation reduced fatigue by almost 50% in women who are low in iron but not anemic, according to the results of a clinical trial published July 9 in CMAJ (Canadian Medical Association Journal).
Cardiome Pharma Corp. (NASDAQ: CRME/TSX: COM) and its co-development partner Astellas Pharma US, Inc. ("Astellas") announced today that Astellas will undertake a single confirmatory additional Phase 3 clinical trial of KYNAPID(TM) (vernakalant hydrochloride) Injection for rapid conversion of atrial fibrillation to sinus rhythm. The trial, to be called ACT 5, is expected to begin enrolling patients by the end of 2009, with completion expected in the first half of 2011.
The American Academy of Physician Assistants and the American College of Physicians today released a policy monograph that supports the critical roles physician assistants and physicians play in improving access to high-quality primary care. The paper, "Internists and Physician Assistants: Team-based Primary Care," results from a months-long collaborative project.
› Verified 5 days ago
News Archive
AbbVie, a global biopharmaceutical company, today announced that it will advance ABT-494, its internally developed investigational selective JAK1 inhibitor, to Phase 3 studies in rheumatoid arthritis. Following a thorough review of available data, AbbVie will not exercise its right to in-license the Galapagos JAK1 inhibitor, filgotinib.
Iron supplementation reduced fatigue by almost 50% in women who are low in iron but not anemic, according to the results of a clinical trial published July 9 in CMAJ (Canadian Medical Association Journal).
Cardiome Pharma Corp. (NASDAQ: CRME/TSX: COM) and its co-development partner Astellas Pharma US, Inc. ("Astellas") announced today that Astellas will undertake a single confirmatory additional Phase 3 clinical trial of KYNAPID(TM) (vernakalant hydrochloride) Injection for rapid conversion of atrial fibrillation to sinus rhythm. The trial, to be called ACT 5, is expected to begin enrolling patients by the end of 2009, with completion expected in the first half of 2011.
The American Academy of Physician Assistants and the American College of Physicians today released a policy monograph that supports the critical roles physician assistants and physicians play in improving access to high-quality primary care. The paper, "Internists and Physician Assistants: Team-based Primary Care," results from a months-long collaborative project.
› Verified 5 days ago
Yaroslav A. Gofnung, M.d., Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 12660 Riverside Dr, Suite 225, North Hollywood, CA 91607 Phone: 818-487-0040 Fax: 818-487-0050 | |
Thesea Chinn Md Mph Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 12660 Riverside Dr, Ste 110, North Hollywood, CA 91607 Phone: 818-766-2110 Fax: 818-508-1463 | |
Magna Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 11755 Victory Blvd, Suite 206, North Hollywood, CA 91606 Phone: 818-762-9883 Fax: 818-762-3237 | |
Oxnard Medical Group Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 12511 Oxnard St, North Hollywood, CA 91606 Phone: 818-762-2084 Fax: 818-762-2085 | |
Nhvc Group Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 12826 Victory Blvd, Suite D, North Hollywood, CA 91606 Phone: 310-819-7059 | |
Dmb Md Group Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7535 Laurel Canyon Blvd, North Hollywood, CA 91605 Phone: 818-962-5505 Fax: 811-821-6722 |